Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment

Stephen P Erickson; Zachary Nahmias; Ilana S Rosman; Kara Sternhell-Blackwell; Amy C Musiek

doi:10.1016/j.jdcr.2018.01.012

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment

JAAD Case Rep. 2018 Feb 28;4(3):245-247. doi: 10.1016/j.jdcr.2018.01.012. eCollection 2018 Apr.

Authors

Stephen P Erickson¹, Zachary Nahmias¹, Ilana S Rosman^{1

2}, Kara Sternhell-Blackwell¹, Amy C Musiek¹

Affiliations

¹ Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
² Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.

No abstract available

Keywords: CLH, cutaneous lymphoid hyperplasia; immunomodulatory; lenalidomide; lymphadenosis benigna cutis; lymphocytoma cutis; pomalidomide; pseudolymphoma.

Publication types

Case Reports